この専門家をプロジェクトに採用したいですか? 見積もりを依頼 無料で。
プロフィール詳細
Dr. Vinayak Khattar, P.に依頼
United States
PhD & MBA powered Analyst, Consultant, & Medical Writer with broad experience in Life Sciences & expertise in Oncology
プロフィール概要
専門分野
サービス
Writing
Clinical Trial Documentation,
Technical Writing,
Newswriting
Research
Fact Checking,
Gray Literature Search,
Systematic Literature Review,
Secondary Data Collection
Product Development
Formulation
職務経験
Consultant | Medical Content Developer
iNDX.Ai - Cupertino, California, US
1月 2019 - 現在
Science Writer | Technology Consultant | Global Scholar
PreScouter - Chicago, Illinois, US
10月 2018 - 現在
Science Writer
Acematiks Inc, Toronto, Canada
9月 2018 - 現在
Medical Content Writer
Medical News Bulletin (Wilderman Medical Clinic), Vaughan, Ontario, Canada
1月 2018 - 現在
Consultant
SmartAnalyst Inc, New York, U.S.
4月 2016 - 現在
Postdoctoral Research Scientist
University of Alabama at Birmingham
6月 2015 - 現在
Science Writer
BioNews Services
2月 2019 - 6月 2019
Graduate Research
University of Alabama at Birmingham
8月 2009 - 5月 2015
学歴
Masters in Business Administration (M.B.A.)
University of Alabama at Birmingham
8月 2015 - 8月 2017
Ph.D. - Biomedical Sciences (Cancer Biology)
University of Alabama at Birmingham
8月 2009 - 5月 2015
Masters in Tehcnology (M.Tech) - Biotechnology
D.Y. Patil University
6月 2004 - 6月 2009
認定資格
- 認定資格の詳細は未入力です。
出版物
JOURNAL ARTICLE
(2018). Recombinant AAV-CEA Tumor Vaccine in Combination with an Immune Adjuvant Breaks Tolerance and Provides Protective Immunity . Molecular therapy oncolytics.
(2018). Structural determinants and genetic modifications enhance BMP2 stability and extracellular secretion . FASEB bioAdvances.
(2018). Characterization of immune cell subtypes in three commonly used mouse strains reveals gender and strain-specific variations . Laboratory investigation; a journal of technical methods and pathology.
(2017). Location of tumor affects local and distant immune cell type and number . Immunity, inflammation and disease.
(2014). Cks1 proteasomal degradation is induced by inhibiting Hsp90-mediated chaperoning in cancer cells . Cancer chemotherapy and pharmacology.
(2014). Cks1 proteasomal turnover is a predominant mode of regulation in breast cancer cells: role of key tyrosines and lysines . International journal of oncology.
(2013). Cks1: Structure, Emerging Roles and Implications in Multiple Cancers . Journal of cancer therapy.